Syk is of particular interest as a target for modulation of B cells in RA in part because of the requirement for this kinase for BCR-derived signals that lead to activation and differentiation to memory B cells and antibody secreting plasma cells. This evidence concerns the gene BCR and rheumatoid arthritis.